Table 2.
Health and Economic Outcomes of CRT-D versus ICD
| Variable | CRT-D | ICD |
|---|---|---|
| Adverse events | ||
| Heartfailure hospitalizations per patient | 0.9 | 1.1 |
| Generator changes per patient | 3.1 | 2.2 |
| Lead failures per patient | 0.3 | 0.2 |
| Lead infections per patient | 0.1 | 0.1 |
| LYs | 9.8 | 8.8 |
| QALYs | 8.6 | 7.6 |
| Lifetime costs, $ | 286 500 | 228 600 |
| Incremental cost perLY and QALY gained versus ICD, $ |
||
| Cost/LY gained | 59 500/LY | - |
| Cost/QALY gained | 61 700/QALY | - |
CRT-D = cardiac resynchronization therapy combined with an implantable cardioverter-defibrillator; ICD = implantable-cardioverter defibrillator; LY = life-year; QALY = quality-adjusted life-year.